Table 2 Medication and related characteristics of adult patients on ART in public health institutions in Harar and Dire Dawa towns, Eastern Ethiopia, 2012
Characteristics | Frequency(N = 620) | Percent (%) |
|---|---|---|
Duration after knowing sero status in weeks | ||
3–12 weeks | 138 | 22.30 |
13–24 weeks | 62 | 10.00 |
>24 weeks | 420 | 67.70 |
Duration after ART initiation in weeks | ||
1–12 weeks | 189 | 30.50 |
13–24 weeks | 62 | 10.00 |
>24 weeks | 369 | 59.50 |
ARV drug used | ||
AZT-3TC-EFV | 116 | 18.7 |
AZT-3TC-NVP | 189 | 30.10 |
D4T-3TC-EFV | 64 | 10.30 |
D4T-3TC-NVP | 64 | 10.30 |
Others | 187 | 30.20 |
Experienced side effects | ||
Yes | 232 | 37.40 |
No | 388 | 62.60 |
Drugs other than ARV | ||
Yes | 462 | 74.50 |
No | 158 | 25.50 |
Number of pills taken in a day | ||
2 tablets | 261 | 42.10 |
3 tablets | 293 | 47.30 |
4 tablets | 53 | 8.50 |
>=5 tablets | 13 | 2.10 |
History of opportunistic infections(OIs) | ||
Yes | 222 | 35.80 |
No | 398 | 64.20 |
Doses of ART status in the last 7 days | ||
Missed | 93 | 15.00 |
Not missed | 527 | 85.00 |
Number of doses missed in last 7 days | ||
1–2 doses | 64 | 69.00 |
3–4 doses | 13 | 14.00 |
5–7 doses | 16 | 17.00 |